Recent advances in mammalian protein production

Ashok D. Bandaranayake, Steven C. Almo

Research output: Contribution to journalReview article

109 Scopus citations

Abstract

Mammalian protein production platforms have had a profound impact in many areas of basic and applied research, and an increasing number of blockbuster drugs are recombinant mammalian proteins. With global sales of these drugs exceeding US$120 billion per year, both industry and academic research groups continue to develop cost effective methods for producing mammalian proteins to support pre-clinical and clinical evaluations of potential therapeutics. While a wide range of platforms have been successfully exploited for laboratory use, the bulk of recent biologics have been produced in mammalian cell lines due to the requirement for post translational modification and the biosynthetic complexity of the target proteins. In this review we highlight the range of mammalian expression platforms available for recombinant protein production, as well as advances in technologies for the rapid and efficient selection of highly productive clones.

Original languageEnglish (US)
Pages (from-to)253-260
Number of pages8
JournalFEBS Letters
Volume588
Issue number2
DOIs
StatePublished - Jan 21 2014

    Fingerprint

Keywords

  • Clonal selection
  • Mammalian expression
  • Protein production
  • Therapeutics

ASJC Scopus subject areas

  • Biophysics
  • Structural Biology
  • Biochemistry
  • Molecular Biology
  • Genetics
  • Cell Biology

Cite this